Results 211 to 220 of about 41,235 (305)
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
Mixed T-domain and TF-domain Magnitude and Phase representations for GAN-based speech enhancement. [PDF]
Lin X, Zhang Y, Wang S.
europepmc +1 more source
Dense CNN with Self-Attention for Time-Domain Speech Enhancement. [PDF]
Pandey A, Wang D.
europepmc +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source
[Neural network for auditory speech enhancement featuring feedback-driven attention and lateral inhibition]. [PDF]
Cai Y, Liu X, Liao X, Zhou Y.
europepmc +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Speech Enhancement for Cochlear Implant Recipients using Deep Complex Convolution Transformer with Frequency Transformation. [PDF]
Mamun N, Hansen JHL.
europepmc +1 more source
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
Deep Learning Based Real-time Speech Enhancement for Dual-microphone Mobile Phones. [PDF]
Tan K, Zhang X, Wang D.
europepmc +1 more source

